Single-Cell Analysis Approaches in Cartilage Diseases Diagnosis and Therapies
Cartilage: From Biology to Biofabrication, Page: 67-95
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Substantial evidence shows that major breakthrough toward cartilage therapeutic approaches is largely hampered by the low chondrocytes yield along with hetero-geneous off-target differentiation of cells during chondrogenesis. Therefore, a complete assessment of an individual cell is essential for exhaustive comprehen-sion of cell-to-cell variability. Nowadays, advances in stem cell biology have empowered the characterization of individual cells and biological mechanisms at the single-cell level. Single-cell analysis technologies represent the ultimate frontier of the transcriptomic landscape of thousands of single cells and revolutionize our understanding of cartilage tissue during normal homeostasis and diseases. Novel technologies like microfluidics and CRISPR/Cas9 technol-ogy are valuable for single-cell omics analysis due to their sensitivity and accuracy. In this chapter, we first present the single-cell profiling of mesenchymal stem cell heterogeneity. Next, we discuss the recent progress in single-cell genomics, epigenomics, and proteomics sequencing technologies. The single-cell multi-omics approaches associated with genomics, transcriptomics, proteo-mics, as well as epigenomics are reviewed to identify cellular subpopulations that drive the disease. We also address their applications in biomarker discovery, personalized medicine, and regenerative medicine with the focus on cartilage tissue.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85208882432&origin=inward; http://dx.doi.org/10.1007/978-981-99-2452-3_4; https://link.springer.com/10.1007/978-981-99-2452-3_4; https://dx.doi.org/10.1007/978-981-99-2452-3_4; https://link.springer.com/chapter/10.1007/978-981-99-2452-3_4
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know